Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,505
Closed -$419K 663
2019
Q2
$419K Buy
+8,505
New +$433K 0.01% 568
2019
Q1
Sell
-8,515
Closed -$522K 785
2018
Q4
$522K Buy
8,515
+26
+0.3% +$1.75K 0.01% 448
2018
Q3
$700K Sell
8,489
-29
-0.3% -$2.3K 0.01% 433
2018
Q2
$666K Buy
8,518
+976
+13% +$75.6K 0.01% 406
2018
Q1
$556K Buy
+7,542
New +$535K 0.01% 442
2017
Q4
Sell
-6,095
Closed -$375K 857
2017
Q3
$375K Buy
6,095
+52
+0.9% +$3.19K 0.01% 609
2017
Q2
$380K Buy
+6,043
New +$344K 0.01% 613

Other funds holding NUS

ING Group's NUS Position: Q3 2019 in Review

ING Group sold out of Nu Skin (NUS) in Q3 2019, closing a stake of 8,505 shares — an estimated $419K sold.

ING Group first reported a position in NUS in Q2 2017 and held it in 7 quarters. The position peaked at $700K in Q3 2018. 235 funds tracked by Wall St. Rank hold NUS as of Q3 2019.

  • ING Group reported no remaining Nu Skin position as of Q3 2019 after selling out during the quarter.
  • ING Group sold 8,505 Nu Skin shares in Q3 2019, an estimated $419K.
  • ING Group first reported a position in Nu Skin in Q2 2017 and held it in 7 quarters.
  • ING Group's Nu Skin position peaked at $700K in Q3 2018.
  • 235 funds tracked by Wall St. Rank held Nu Skin as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.